The store will not work correctly when cookies are disabled.
1-(Methyl)-3-((5,7-dimethyl-2H-chromen-2-one-4-yl)methyl)imidazolium chloride
ID: ALA3759775
PubChem CID: 127027355
Max Phase: Preclinical
Molecular Formula: C16H17ClN2O2
Molecular Weight: 269.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(C)c2c(C[n+]3ccn(C)c3)cc(=O)oc2c1.[Cl-]
Standard InChI: InChI=1S/C16H17N2O2.ClH/c1-11-6-12(2)16-13(8-15(19)20-14(16)7-11)9-18-5-4-17(3)10-18;/h4-8,10H,9H2,1-3H3;1H/q+1;/p-1
Standard InChI Key: UOJCLMIZPZIYAM-UHFFFAOYSA-M
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
6.3926 -2.7103 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.7213 -5.2356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 -3.7544 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9399 -3.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9409 -4.2538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1878 -5.5510 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 -2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6486 1.3517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6321 1.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -2.6973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6732 -6.6484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
2 6 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
16 17 1 0
8 17 1 0
8 18 2 0
14 19 1 0
12 20 1 0
7 10 1 0
3 7 1 0
6 21 1 0
M CHG 2 1 -1 3 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.32 | Molecular Weight (Monoisotopic): 269.1285 | AlogP: 2.08 | #Rotatable Bonds: 2 |
Polar Surface Area: 39.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: -1.12 | CX LogD: -1.12 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.53 | Np Likeness Score: -0.09 |
References
1. Karataş MO, Uslu H, Alıcı B, Gökçe B, Gencer N, Arslan O, Arslan NB, Özdemir N.. (2016) Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies., 24 (6): [PMID:26879855] [10.1016/j.bmc.2016.02.012] |